Immunomodulating Therapies in Breast Cancer-From Prognosis to Clinical Practice.

Cancers (Basel) · 2021 · PMC8507771 · PMID 34638367

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

76.8%) and reported a strong trend towards longer OS (HR 0.72; 95% CI 0.51–1.02).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.